No profile data available.
Qiagen N.v. (QGEN) is a healthcare company in the DNA testing equipment industry, based in Venlo, Netherlands, with about 5,500 full-time employees.
It reported revenue of $2.09 billion for fiscal year 2025, up 5.7% from fiscal year 2024, and net income of $424.88 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $535.04 million, up 0.3% from a year before. United States was its largest region in fiscal year 2025, with 48% of revenue. Its market capitalization was $9.37 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
V. provides sample to insight solutions that transform biological samples into molecular insights worldwide.
Qiagen reported $2.09 billion in revenue for fiscal year 2025, up 5.7% from $1.98 billion in fiscal year 2024. In Q2 2026 revenue was $535.04 million.
United States: 48% of revenue by region in fiscal year 2025, followed by Europe, Middle East and Africa (34%).
$9.37 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include Natera, Inc. (NTRA), Guardant Health, Inc. (GH), Tempus AI, Inc. (TEM), Caris Life Sciences, Inc. (CAI).